Literature DB >> 28937839

TZA: a novel assay for measuring the latent HIV-1 reservoir.

Phalguni Gupta1,2, Anwesha Sanyal1, Robbie B Mailliard1.   

Abstract

Entities:  

Keywords:  Latent HIV-1; TZA

Mesh：

Year:  2017        PMID： 28937839      PMCID： PMC5821502          DOI： 10.1080/14737159.2017.1384315

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


× No keyword cloud information.
  34 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

3.  Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.

Authors:  Janet D Siliciano; Robert F Siliciano
Journal:  Methods Mol Biol       Date:  2005

4.  Absence of detectable HIV-1 viremia after treatment cessation in an infant.

Authors:  Deborah Persaud; Hannah Gay; Carrie Ziemniak; Ya Hui Chen; Michael Piatak; Tae-Wook Chun; Matthew Strain; Douglas Richman; Katherine Luzuriaga
Journal:  N Engl J Med       Date:  2013-10-23       Impact factor: 91.245

5.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

6.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 7.  How Much HIV is Alive? The Challenge of Measuring Replication Competent HIV for HIV Cure Research.

Authors:  Jintanat Ananworanich; John W Mellors
Journal:  EBioMedicine       Date:  2015-07-29       Impact factor: 8.143

8.  A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

Authors:  Francesco Andrea Procopio; Rémi Fromentin; Deanna A Kulpa; Jessica H Brehm; Anne-Gaelle Bebin; Matthew C Strain; Douglas D Richman; Una O'Doherty; Sarah Palmer; Frederick M Hecht; Rebecca Hoh; Richard J O Barnard; Michael D Miller; Daria J Hazuda; Steven G Deeks; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  EBioMedicine       Date:  2015-06-27       Impact factor: 8.143

9.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

10.  Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.

Authors:  Elizabeth Hamlyn; Fiona M Ewings; Kholoud Porter; David A Cooper; Giuseppe Tambussi; Mauro Schechter; Court Pedersen; Jason F Okulicz; Myra McClure; Abdel Babiker; Jonathan Weber; Sarah Fidler
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240
View more
  5 in total

1.  Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model.

Authors:  Jasmine Samal; Samantha Kelly; Ali Na-Shatal; Abdallah Elhakiem; Antu Das; Ming Ding; Anwesha Sanyal; Phalguni Gupta; Kevin Melody; Brad Roland; Watfa Ahmed; Aala Zakir; Moses Bility
Journal:  JCI Insight       Date:  2018-09-20

Review 2.  Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies.

Authors:  Min Chen; Min Li; Marietta M Budai; Andrew P Rice; Jason T Kimata; Mahesh Mohan; Jin Wang
Journal:  J Leukoc Biol       Date:  2022-03-31       Impact factor: 6.011

3.  Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana.

Authors:  Catherine K Koofhethile; Sikhulile Moyo; Kenanao P Kotokwe; Charlotte Chang; Patrick Mokgethi; Lorato Muchoba; Selebogo Mokgweetsi; Joseph Makhema; Shahin Lockman; Simani Gaseitsiwe; Tulio de Oliveira; M Essex; Roger Shapiro; Phyllis Kanki; Vladimir Novitsky
Journal:  AIDS Res Hum Retroviruses       Date:  2020-10-19       Impact factor: 2.205

4.  Clearance of HIV infection by selective elimination of host cells capable of producing HIV.

Authors:  Min Li; Wei Liu; Tonya Bauch; Edward A Graviss; Roberto C Arduino; Jason T Kimata; Min Chen; Jin Wang
Journal:  Nat Commun       Date:  2020-08-13       Impact factor: 14.919

5.  Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice.

Authors:  Hang Su; Sruthi Sravanam; Santhi Gorantla; Rafal Kaminski; Kamel Khalili; Larisa Poluektova; Howard E Gendelman; Prasanta K Dash
Journal:  Front Cell Infect Microbiol       Date:  2020-02-11       Impact factor: 5.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.